AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2486945 — intervention group
Group type: COMPARATOR
Intervention: Crystallography
Number of subjects: 116
Study 31796061 — intervention group
Group type: EXPERIMENTAL
Intervention: Chat-bot with evidence-based contents to help quit smoking
Number of subjects: 460
Study 31796061 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment according to the protocol for tobacco cessation by the Madrid Regional Health Service
Number of subjects: 460
Study 28865441 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarticular corticosteroid injections
Number of subjects: 105
Study 28865441 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 105
Study 28865441 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychometric parameters (Pseudoneurology subscale in SHC)
Number of subjects: 105
Study 28865441 — intervention group
Group type: EXPERIMENTAL
Intervention: Being female
Number of subjects: 105
Study 25092528 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-exhaustion training (n = 14)
Number of subjects: 39
Study 25092528 — intervention group
Group type: EXPERIMENTAL
Intervention: Same exercise order with a rest interval between exercises (n = 17)
Number of subjects: 39
Study 25092528 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 8) performing exercises in a different order (compound exercises prior to isolation)
Number of subjects: 39
Study 22430092 — intervention group
Group type: EXPERIMENTAL
Intervention: New operation group (n=453)
Number of subjects: 969
Study 22430092 — intervention group
Group type: COMPARATOR
Intervention: Conventional group (n=516)
Number of subjects: 969
Study 19220519 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention on Ni-Ti rotary system in Intervention County (IC)
Number of subjects: 195
Study 19220519 — intervention group
Group type: COMPARATOR
Intervention: No educational intervention in Control County (CC)
Number of subjects: 195
Study 17913754 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 MAC sevoflurane administered via the ventilator for 15 min followed by a 15 min washout before CPB
Number of subjects: 72
Study 17913754 — intervention group
Group type: COMPARATOR
Intervention: Control group (no sevoflurane administration)
Number of subjects: 72
Study 17913754 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 MAC sevoflurane
Number of subjects: 72
Study 16131559 — intervention group
Group type: EXPERIMENTAL
Intervention: Tidal volume of 6 ml/kg
Number of subjects: 0
Study 16131559 — intervention group
Group type: COMPARATOR
Intervention: Tidal volume of 12 ml/kg
Number of subjects: 0
Study 11866252 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard naltrexone plus low-value contingency management (CM)
Number of subjects: 55
Study 11866252 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard naltrexone plus high-value contingency management (CM)
Number of subjects: 55
Study 11866252 — intervention group
Group type: COMPARATOR
Intervention: Standard naltrexone treatment
Number of subjects: 55
Study 11866252 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard naltrexone plus low-value CM
Number of subjects: 55
Study 11866252 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard naltrexone plus high-value CM
Number of subjects: 55
Study 10361962 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide 450 mg per day
Number of subjects: 135
Study 10361962 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine 150 mg per day
Number of subjects: 135
Study 8963358 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-bout exercise group (SB, n = 28)
Number of subjects: 56
Study 8963358 — intervention group
Group type: COMPARATOR
Intervention: Long-bout exercise group (LB, n = 28)
Number of subjects: 56
Study 1723407 — intervention group
Group type: EXPERIMENTAL
Intervention: Current chemotherapy for advanced testicular cancer
Number of subjects: 0
Study 1723407 — intervention group
Group type: EXPERIMENTAL
Intervention: New regimens evaluated in randomized trials
Number of subjects: 0
Study 7258824 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% FPL‐55712 (SRS‐A antagonist)
Number of subjects: 6
Study 7258824 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% FPL‐55712 (SRS‐A antagonist)
Number of subjects: 6
Study 7258824 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 31955502 — intervention group
Group type: EXPERIMENTAL
Intervention: More experienced abstractors
Number of subjects: 50
Study 31955502 — intervention group
Group type: COMPARATOR
Intervention: Less experienced abstractors
Number of subjects: 50
Study 31629764 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous BFR (cBFR)
Number of subjects: 14
Study 31629764 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent BFR (iBFR)
Number of subjects: 14
Study 31629764 — intervention group
Group type: COMPARATOR
Intervention: Low-load RE without BFR (LI)
Number of subjects: 14
Study 31629764 — intervention group
Group type: COMPARATOR
Intervention: Traditional high-load RE (HI)
Number of subjects: 14
Study 27779809 — intervention group
Group type: EXPERIMENTAL
Intervention: Perinatal probiotics (Lactobacillus rhamnosus GG, Bifidobacterium lactis Bb‐12, Lactobacillus paracasei ST11, Bifidobacterium longum BL999)
Number of subjects: 303
Study 27779809 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG
Number of subjects: 303
Study 27779809 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 303
Study 27779809 — intervention group
Group type: EXPERIMENTAL
Intervention: Perinatal probiotics (general)
Number of subjects: 303
Study 26105008 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 7
Study 26105008 — intervention group
Group type: COMPARATOR
Intervention: Saline (CON)
Number of subjects: 7
Study 23534456 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher-GI carbohydrates
Number of subjects: 21955
Study 23534456 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-GI carbohydrates
Number of subjects: 21955
Study 23534456 — intervention group
Group type: EXPERIMENTAL
Intervention: Replacement of saturated and trans-fatty acids with carbohydrates
Number of subjects: 21955
Study 23534456 — intervention group
Group type: EXPERIMENTAL
Intervention: Replacement of MUFA with carbohydrates
Number of subjects: 21955
Study 20522167 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ and IV insulin therapy
Number of subjects: 17
Study 20522167 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 17
Study 19270234 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous peritoneal dialysis (CPD)
Number of subjects: 120
Study 19270234 — intervention group
Group type: COMPARATOR
Intervention: Daily hemodialysis (dHD)
Number of subjects: 120
Study 17365745 — intervention group
Group type: EXPERIMENTAL
Intervention: d,l-fenfluramine
Number of subjects: 593
Study 17365745 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 593
Study 15128636 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane 1 to 3% with 60% nitrous oxide in oxygen
Number of subjects: 103
Study 15128636 — intervention group
Group type: COMPARATOR
Intervention: Propofol 4 to 10 mg x kg(‐1) x hr(‐1) with 60% nitrous oxide in oxygen
Number of subjects: 103
Study 11260586 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrotherapy (37 degrees C water for 1 hr during early labor)
Number of subjects: 18
Study 11260586 — intervention group
Group type: COMPARATOR
Intervention: Control (nonbathers)
Number of subjects: 18
Study 9561872 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyurethane condom
Number of subjects: 360
Study 9561872 — intervention group
Group type: COMPARATOR
Intervention: Latex condom
Number of subjects: 360
Study 7872995 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol sulfate (Asmasal) at 0.1 mg/kg
Number of subjects: 11
Study 7872995 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol sulfate (Asmasal) at 0.2 mg/kg
Number of subjects: 11
Study 7872995 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol sulfate (Asmasal) at 0.3 mg/kg
Number of subjects: 11
Study 3243221 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom curriculum
Number of subjects: 1839
Study 3243221 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based curriculum
Number of subjects: 1839
Study 3243221 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of classroom and home-based curriculum
Number of subjects: 1839
Study 3243221 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1839
Study 29192349 — intervention group
Group type: EXPERIMENTAL
Intervention: Placement of an antibiotic oral pack on the hard palate for 5 days postoperatively (Group A)
Number of subjects: 200
Study 29192349 — intervention group
Group type: COMPARATOR
Intervention: No oral pack placed (Group B)
Number of subjects: 200
Study 27404011 — intervention group
Group type: EXPERIMENTAL
Intervention: Make-The-Cut-Plus (MTC+) intervention
Number of subjects: 1226
Study 27404011 — intervention group
Group type: COMPARATOR
Intervention: Control group (received MTC+ at the end of the period)
Number of subjects: 1226
Study 24000883 — intervention group
Group type: EXPERIMENTAL
Intervention: Interprofessional education (IPE) debate in ethics and professionalism
Number of subjects: 0
Study 22452894 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone therapy plus celecoxib (arm D)
Number of subjects: 2043
Study 22452894 — intervention group
Group type: COMPARATOR
Intervention: Hormone therapy alone (control arm A)
Number of subjects: 2043
Study 20736674 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation training in ultrasound-guided central venous catheter insertion (CVC)
Number of subjects: 185
Study 20736674 — intervention group
Group type: COMPARATOR
Intervention: Traditional bedside apprenticeship model
Number of subjects: 185
Study 17609682 — intervention group
Group type: EXPERIMENTAL
Intervention: Efavirenz
Number of subjects: 50
Study 17609682 — intervention group
Group type: EXPERIMENTAL
Intervention: Nelfinavir
Number of subjects: 50
Study 17609682 — intervention group
Group type: EXPERIMENTAL
Intervention: Efavirenz and Nelfinavir
Number of subjects: 50
Study 17609682 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose adjustment
Number of subjects: 50
Study 15806597 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine (CMI)
Number of subjects: 0
Study 15806597 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure and ritual prevention (EX/RP)
Number of subjects: 0
Study 15806597 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of EX/RP and CMI (EX/RP+CMI)
Number of subjects: 0
Study 15806597 — intervention group
Group type: EXPERIMENTAL
Intervention: EX/RP (with or without CMI)
Number of subjects: 0
Study 15806597 — intervention group
Group type: COMPARATOR
Intervention: CMI alone
Number of subjects: 0
Study 12226610 — intervention group
Group type: EXPERIMENTAL
Intervention: new brackets
Number of subjects: 120
Study 12226610 — intervention group
Group type: EXPERIMENTAL
Intervention: rebonded/sandblasted/sealant
Number of subjects: 120
Study 12226610 — intervention group
Group type: EXPERIMENTAL
Intervention: rebonded/sandblasted/silane
Number of subjects: 120
Study 12226610 — intervention group
Group type: EXPERIMENTAL
Intervention: rebonded/sandblasted
Number of subjects: 120
Study 12226610 — intervention group
Group type: EXPERIMENTAL
Intervention: rebonded/sandblasted/HF
Number of subjects: 120
Study 12226610 — intervention group
Group type: EXPERIMENTAL
Intervention: rebonded/sandblasted/HF/sealant
Number of subjects: 120
Study 10217646 — intervention group
Group type: EXPERIMENTAL
Intervention: Preconditioning (PC) during PTCA
Number of subjects: 150
Study 10217646 — intervention group
Group type: COMPARATOR
Intervention: Unrestricted approach to balloon angioplasty (UC)
Number of subjects: 150
Study 7879933 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium (0.5 mg.kg-1)
Number of subjects: 16
Study 7879933 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium (0.1 mg.kg-1)
Number of subjects: 16
Study 2196355 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone, 2 mg/kg/day by intravenous injection during the first 7 days of life (group A1)
Number of subjects: 466
Study 2196355 — intervention group
Group type: COMPARATOR
Intervention: 10% dextrose solution placebo (group A2)
Number of subjects: 466
Study 2196355 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal betamethasone (group B)
Number of subjects: 466
Study 2196355 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (group A1)
Number of subjects: 466
Study 7005306 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine
Number of subjects: 58
Study 7005306 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 30659815 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term ontopsychological psychotherapy plus routine medical therapy
Number of subjects: 94
Study 30659815 — intervention group
Group type: COMPARATOR
Intervention: Routine medical therapy only
Number of subjects: 94
Study 25985845 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA‐P Group
Number of subjects: 58
Study 25985845 — intervention group
Group type: EXPERIMENTAL
Intervention: ETT Group
Number of subjects: 58
Study 25985845 — intervention group
Group type: COMPARATOR
Intervention: DLT Group
Number of subjects: 58
Study 23389795 — intervention group
Group type: EXPERIMENTAL
Intervention: Training on anatomic dry models
Number of subjects: 14
Study 23389795 — intervention group
Group type: COMPARATOR
Intervention: Training only on cadaveric specimens
Number of subjects: 14
Study 23389795 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry-model training
Number of subjects: 14
Study 20147571 — intervention group
Group type: EXPERIMENTAL
Intervention: MRK-409 at a dose of 2 mg
Number of subjects: 0
Study 20147571 — intervention group
Group type: COMPARATOR
Intervention: MRK-409 at a dose of 1 mg
Number of subjects: 0
Study 20147571 — intervention group
Group type: EXPERIMENTAL
Intervention: Rodent models of anxiety
Number of subjects: 0
Study 20147571 — intervention group
Group type: EXPERIMENTAL
Intervention: Rodent models
Number of subjects: 0
Study 20147571 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19672771 — intervention group
Group type: EXPERIMENTAL
Intervention: CDA 0.14 mg/kg/day for 5 days (Arm A)
Number of subjects: 100
Study 19672771 — intervention group
Group type: COMPARATOR
Intervention: CDA 0.14 mg/kg/day once weekly for 5 weeks (Arm B)
Number of subjects: 100
Study 17099023 — intervention group
Group type: EXPERIMENTAL
Intervention: Dosimeter method
Number of subjects: 25
Study 17099023 — intervention group
Group type: COMPARATOR
Intervention: Tidal-breathing method
Number of subjects: 25
Study 15100717 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.5 g/day fish oil (1.5 g/day n-3 fatty acids)
Number of subjects: 84
Study 15100717 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 11167438 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg at induction and ondansetron 0.13 mg with each 1-mg bolus dose of morphine
Number of subjects: 142
Study 11167438 — intervention group
Group type: COMPARATOR
Intervention: Droperidol 0.5 mg at induction and droperidol 0.05 mg per 1-mg bolus dose of morphine
Number of subjects: 142
Study 9924238 — intervention group
Group type: EXPERIMENTAL
Intervention: itraconazole 200 mg orally, once daily for 4 days
Number of subjects: 10
Study 9924238 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study 7508827 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium chloride (0.3 mEq/kg bolus over 10 minutes followed by 0.08 mEq/kg per hour for 24 hours)
Number of subjects: 30
Study 7508827 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous magnesium chloride
Number of subjects: 30
Study 7508827 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5% dextrose in water)
Number of subjects: 30
Study 7508827 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 2906956 — intervention group
Group type: EXPERIMENTAL
Intervention: labetalol (1 mg/kg i.v. 15 min)
Number of subjects: 32
Study 2906956 — intervention group
Group type: EXPERIMENTAL
Intervention: nifedipine (20 mg sublingually)
Number of subjects: 32
Study 29318916 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable activity tracker (Misfit Flash) provided to students in the intervention group
Number of subjects: 187
Study 29318916 — intervention group
Group type: COMPARATOR
Intervention: Control group (no wearable activity tracker)
Number of subjects: 187
Study 29318916 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (wearable activity tracker)
Number of subjects: 187
Study 27438294 — intervention group
Group type: EXPERIMENTAL
Intervention: Philani Intervention Program (PIP) with home visits by Community Health Workers (CHW)
Number of subjects: 1238
Study 27438294 — intervention group
Group type: EXPERIMENTAL
Intervention: Philani Intervention Program (PIP)
Number of subjects: 1238
Study 27438294 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 1238
Study 24726210 — intervention group
Group type: EXPERIMENTAL
Intervention: losartan 150 mg/d
Number of subjects: 3846
Study 24726210 — intervention group
Group type: COMPARATOR
Intervention: losartan 50 mg/d
Number of subjects: 3846
Study 23275363 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide once weekly (EQW) 2 mg
Number of subjects: 216
Study 23275363 — intervention group
Group type: COMPARATOR
Intervention: Insulin detemir (once or twice daily, titrated)
Number of subjects: 216
Study 23275363 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide once weekly (EQW)
Number of subjects: 216
Study 23275363 — intervention group
Group type: COMPARATOR
Intervention: Insulin detemir
Number of subjects: 216
Study 21988800 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care (a low intensity psychological intervention in addition to usual general practitioner care)
Number of subjects: 540
Study 21988800 — intervention group
Group type: COMPARATOR
Intervention: Usual general practitioner care alone
Number of subjects: 540
Study 18422677 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with intractable epilepsy (IE)
Number of subjects: 25
Study 18422677 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with intractable epilepsy (IE) and cerebral palsy (CP)
Number of subjects: 25
Study 18422677 — intervention group
Group type: COMPARATOR
Intervention: Healthy children
Number of subjects: 25
Study 16931258 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 0.4% for 3 days
Number of subjects: 100
Study 16931258 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 0.4% for 1 day
Number of subjects: 100
Study 16931258 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 0.4% for 1 hour
Number of subjects: 100
Study 16931258 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 12743562 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific immunotherapy with a standardized latex extract
Number of subjects: 24
Study 12743562 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 10974044 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation (200 mg of DHA/day)
Number of subjects: 10
Study 10974044 — intervention group
Group type: COMPARATOR
Intervention: Placebo oil
Number of subjects: 10
Study 10974044 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation
Number of subjects: 10
Study 8733069 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol 50 mg bid
Number of subjects: 29
Study 8733069 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol 25 mg bid
Number of subjects: 29
Study 8733069 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous carvedilol followed by oral carvedilol 50 mg bid for 8 weeks
Number of subjects: 29
Study 1303781 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunologically active peat preparation (PTT)
Number of subjects: 0
Study 1303781 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3510946 — intervention group
Group type: EXPERIMENTAL
Intervention: cis-dichlorodiammine platinum (II) (cis-DPP) with radiation
Number of subjects: 45
Study 3510946 — intervention group
Group type: COMPARATOR
Intervention: radiation
Number of subjects: 45
Study 28941040 — intervention group
Group type: EXPERIMENTAL
Intervention: TPB messages
Number of subjects: 2951
Study 28941040 — intervention group
Group type: COMPARATOR
Intervention: Self-affirmation and implementation intentions
Number of subjects: 2951
Study 26946967 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic S. boulardii (50 mg/kg twice daily)
Number of subjects: 125
Study 26946967 — intervention group
Group type: COMPARATOR
Intervention: Control group (no probiotic)
Number of subjects: 125
Study 23596009 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention to reduce the n-6/n-3 fatty acid ratio from 15th week of gestation until 4 months postpartum
Number of subjects: 208
Study 23596009 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 208
Study 23596009 — intervention group
Group type: EXPERIMENTAL
Intervention: Cord leptin
Number of subjects: 208
Study 22631051 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent bolus application of propofol
Number of subjects: 100
Study 22631051 — intervention group
Group type: COMPARATOR
Intervention: Continuous infusion of propofol
Number of subjects: 100
Study 20456855 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal care visits provided by a community midwife at a local clinic, 10 visits
Number of subjects: 100
Study 20456855 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal care visits provided by a community midwife at a local clinic
Number of subjects: 100
Study 20456855 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal care visits provided by midwives with enhanced service provision
Number of subjects: 100
Study 19024097 — intervention group
Group type: EXPERIMENTAL
Intervention: Firebird sirolimus eluting stent (SES)
Number of subjects: 509
Study 19822590 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery treatment
Number of subjects: 34
Study 19822590 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care only
Number of subjects: 34
Study 19822590 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery treatment after standard medical care
Number of subjects: 34